Business UpdateSep 16, 2026, 07:31 AM
Aurora Cannabis Updates Business; Safari Acquisition to Fuel International Growth
AI Summary
Aurora Cannabis provided a business update highlighting the expected benefits from the Safari Flower Company acquisition and strong international performance. The company reaffirmed its fiscal year 2027 Q2 guidance for sequential growth in net revenue and adjusted EBITDA. The acquisition of Safari Flower Company, which received EU-GMP certification, is expected to add incremental revenue and EBITDA. Aurora also noted continued strong performance in Germany and Poland, reinforcing its leadership in key European markets, and ongoing expansion in the UK.
Key Highlights
- Aurora Cannabis reaffirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA.
- Safari Flower Company acquisition expected to contribute incremental net revenue and adjusted EBITDA post EU-GMP certification.
- Continued strong performance in Germany and Poland, contributing to profitable international growth and #1 market share in Poland.
- UK market expansion underway with acquisitions of Internode Pharma and HAP Pharma Limited to support market share growth.
- Company has $149 million in cash and no debt as of June 30, 2026.
Price Impact
More from ACB